San Jose, California (PRWEB) February 05, 2014
Follow us on LinkedIn - Defined as the process of removal of contaminated, dead or adherent tissue from a wound to promote healing, debridement represents an important part of the wound management process. Wounds that often need to undergo a debridement procedure include chronic wounds such as pressure ulcers, diabetic foot ulcers and surgical wounds that get infected subsequent to surgery. Debridement performed at an early stage accelerates wound healing, which consequently improves patient health, reduces hospital stays and overall treatment costs.
The market for wound debridement products continues to witness steady growth driven by growing incidence of chronic wounds due to an expanding base of aging population and increasing prevalence of diseases such as diabetes. Increasing life expectancy, changing lifestyles, and heightened awareness about the benefits of timely wound management are also driving demand for these products. Growing acceptance of wound bed preparation techniques in various clinical settings also bodes well for the market.
To ensure patient compliance, efforts are increasingly being focused on developing products that facilitate painless treatment. Apart from efficacy, the aspect of speed in debriding is also gaining attention. Surgical debridement in addition to autolytic, larval and more recently ultrasonic and hydrosurgery are some of the most commonly used debridement methods for the treatment of chronic wounds. Pulsed, non-thermal, low-frequency ultrasound that improves inflammatory response and tissue repair is an innovative debridement method that has been found to offer better healing rates for recalcitrant foot ulcers. Larvae therapy or maggot debridement therapy which until now has largely been under used is re-emerging due to growing incidence of chronic wounds and the surge in strains of bacteria such as MRSA.
As stated by the new market research report on Wound Debridement Products, the United States represents the largest market worldwide. Asia Pacific is forecast to emerge as the fastest growing market with a CAGR of 8.1% over the analysis period. Growth in Asia-Pacific is primarily supported by improving standards of living, demand for better healthcare, and shift to advanced wound debridement products.
Major players in the market include Advanced Medical Solutions Group plc, ArthroCare Corporation, Coloplast, Derma Sciences Inc., Misonix, PuriCore plc, Smith & Nephew Plc and MediWound Ltd., among others.
The research report titled “Wound Debridement Products: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, mergers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections in US dollars for all major geographic markets including the United States, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/